-
Mashup Score: 0
Scientists used to dismiss the notion that the Y chromosome plays a role in cancer. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0NCI Trials for July 2023 - The Cancer Letter - 2 year(s) ago
The National Cancer Institute approved the following clinical research studies last month. For further information, contact the principal investigator listed. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NCI Trials for July 2023. https://t.co/6ORbCMAzw9 https://t.co/aggAgrBDKn
-
-
Mashup Score: 0
In May 1991, I sat in a law firm conference room in Washington, DC, listening to a pitch from a small group of women who had the idea to launch a political advocacy movement around breast cancer. One of those women was Dr. Susan Love. The person next to me nudged me with her elbow […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Fran Visco (@FranMVisco, @NBCCStopBC) writes: NBCC likely would not exist if it were not for Sue Love. https://t.co/xcnBeaIamd
-
-
Mashup Score: 0
Scientists used to dismiss the notion that the Y chromosome plays a role in cancer. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The Y chromosome has been dissed as a "functional wasteland." But last month, a team at @CedarsSinai published a fundamental biological finding: loss of the Y makes cancer worse, & it does so by boosting the tumor’s ability to evade the immune system. https://t.co/jkef5Gh8nF
-
-
Mashup Score: 0Can ctDNA be used as an endpoint for cancer drug development? Friends collaboration to present initial results July 11 - The Cancer Letter - 2 year(s) ago
As researchers consider using circulating tumor DNA as an endpoint in clinical trials to evaluate drug efficacy, a collaboration led by Friends of Cancer Research is creating the evidentiary roadmap for the use of ctDNA in regulatory decisions. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
These research questions are the focus of the multiphase collaboration between @CancerResrch, FDA, NCI, clinical researchers, pharmaceutical companies, and diagnostics companies. https://t.co/wGBJu2456f
-
-
Mashup Score: 2FDA grants priority review to zolbetuximab for gastroesophageal junction adenocarcinoma - The Cancer Letter - 2 year(s) ago
FDA has accepted and the Biologics License Application for zolbetuximab, a first-in-class investigational Claudin 18.2-targeted monoclonal antibody, for first-line treatment of patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma whose tumors are CLDN18.2-positive. To access this subscriber-only content please log in or renew…
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
FDA grants priority review to zolbetuximab for gastroesophageal junction adenocarcinoma. https://t.co/W2KBUhmL52 https://t.co/WFEnYkLboF
-
-
Mashup Score: 0Threats to the NCI COE agenda impede our ability to meet the needs of our cancer center catchment area communities - The Cancer Letter - 2 year(s) ago
Community Outreach and Engagement (COE), now augmented with the Plan to Enhance Diversity (PED), is critical and central to the impact of NCI-designated cancer centers, and both are set forth as required components for the NCI Cancer Center Support Grant (CCSG). To access this subscriber-only content please log in or renew your subscription.Looking for IP […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Alliance of Black COE Scientific Directors: "Health equity requires intentional action. Therefore, hosting these important conversations will require a departure from business as usual." https://t.co/xHmoeJf2kN
-
-
Mashup Score: 0Crapo, Bennet, Cardin, and Scott introduce legislation to expand coverage of MCEDs - The Cancer Letter - 2 year(s) ago
On June 22, Sens. Mike Crapo (R-ID), Michael Bennet (D-CO), Ben Cardin (D-MD), and Tim Scott (R-SC) introduced the Medicare Multi-Cancer Early Detection Screening Coverage Act, which would grant Medicare the authority to cover multi-cancer early detection tests once they are approved by FDA. To access this subscriber-only content please log in or renew your […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
.@MikeCrapo, @SenatorBennet, @SenatorCardin, and @SenatorTimScott introduce legislation to expand coverage of MCEDs. https://t.co/RYAPhBLa6A
-
-
Mashup Score: 1
In May 1991, I sat in a law firm conference room in Washington, DC, listening to a pitch from a small group of women who had the idea to launch a political advocacy movement around breast cancer. One of those women was Dr. Susan Love. The person next to me nudged me with her elbow […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Fran Visco (@NBCCStopBC) on Susan Love: "Not long after she learned her leukemia had recurred, she spoke about her work with NBCC and ended with this: 'We have certainly had a great run.' Without Sue, we would still be crawling. Thank you, my friend." https://t.co/xcnBeaIamd
-
-
Mashup Score: 0Threats to the NCI COE agenda impede our ability to meet the needs of our cancer center catchment area communities - The Cancer Letter - 2 year(s) ago
Community Outreach and Engagement (COE), now augmented with the Plan to Enhance Diversity (PED), is critical and central to the impact of NCI-designated cancer centers, and both are set forth as required components for the NCI Cancer Center Support Grant (CCSG). To access this subscriber-only content please log in or renew your subscription.Looking for IP […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
"The imperative of COE is...accelerated by the increasingly visible killings of unarmed Black and brown people, and the heightened public awareness of health disparities which became painfully apparent during the COVID-19 pandemic." https://t.co/xHmoeJfAal
-
.@Dan_Theodorescu: "I want to emphasize the importance of awareness to sex and gender across the entire spectrum of cancer research and care. We need to really consider this interplay between the chromosomes and the hormonal microenvironment in cancer." https://t.co/jkef5GgAy7